{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:08:09Z","timestamp":1788988089674,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018810","name":"VILLUM Center for Bioanalytical Sciences","doi-asserted-by":"publisher","award":["VKR023179"],"award-info":[{"award-number":["VKR023179"]}],"id":[{"id":"10.13039\/501100018810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017325","name":"Engineering Research Centers","doi-asserted-by":"publisher","award":["101088163 EMMA"],"award-info":[{"award-number":["101088163 EMMA"]}],"id":[{"id":"10.13039\/100017325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"Horizon 2020 MSCA","doi-asserted-by":"publisher","award":["110361"],"award-info":[{"award-number":["110361"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bbapap.2026.141174","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:59:18Z","timestamp":1787756358000},"page":"141174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Native structure of the therapeutic IgG4 \u03b14\u03b25 integrin antibody natalizumab"],"prefix":"10.1016","volume":"1874","author":[{"given":"Victor G.","family":"Chrone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan C.","family":"Jespersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daut C.","family":"Asani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Hieronymus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumik","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole H.","family":"Trier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jette L.","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"H\u00f8jrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Houen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbapap.2026.141174_bb0005","series-title":"StatPearls [Internet]","article-title":"Natalizumab","author":"Babaesfahani","year":"2025"},{"key":"10.1016\/j.bbapap.2026.141174_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103995","article-title":"Use of natalizumab in persons with multiple sclerosis: 2022 update","volume":"65","author":"Morrow","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.bbapap.2026.141174_bb0015","doi-asserted-by":"crossref","first-page":"32314","DOI":"10.1074\/jbc.M113.501668","article-title":"How natalizumab binds and antagonizes \u03b14 integrins","volume":"288","author":"Yu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2026.141174_bb0020","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1212\/01.WNL.0000158329.30470.D0","article-title":"Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale","volume":"26","author":"Rice","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.bbapap.2026.141174_bb0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jneuroim.2015.08.010","article-title":"Upregulation of integrin expression on monocytes in multiple sclerosis patients treated with natalizumab","volume":"15","author":"Dallari","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbapap.2026.141174_bb0030","first-page":"1433","article-title":"Natalizumab in the treatment of Crohn's disease patients","volume":"17","author":"Pagnini","year":"2017","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.bbapap.2026.141174_bb0035","article-title":"Natalizumab-associated progressive multifocal leukoencephalopathy","volume":"20","author":"Glenn","year":"2025","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbapap.2026.141174_bb0040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2217\/imt-2016-0113","article-title":"Natalizumab treatment of multiple sclerosis: new insights","volume":"9","author":"Delbue","year":"2017","journal-title":"Immunotherapy"},{"key":"10.1016\/j.bbapap.2026.141174_bb0045","doi-asserted-by":"crossref","unstructured":"J. Giorgetti, V. D'Atri, J. Canonge, A. Lechner, D. Guillarme, O. Colas, E. Wagner-Rousset, A. Beck, E. Leize-Wagner, Y.N. Fran\u00e7ois, Monoclonal antibody N-glycosylation profiling using capillary electrophoresis - mass spectrometry: assessment and method validation, Talanta 1 (2018) 178:530\u2013537, doi:https:\/\/doi.org\/10.1016\/j.talanta.2017.09.083.","DOI":"10.1016\/j.talanta.2017.09.083"},{"key":"10.1016\/j.bbapap.2026.141174_bb0050","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/14740338.2017.1346082","article-title":"Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis","volume":"16","author":"Clerico","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.bbapap.2026.141174_bb0055","doi-asserted-by":"crossref","unstructured":"P. Chamberlain, B. Hemmer, J. H\u00f6fler, H. Wessels, O. von Richter, C. Hornuss, J. Poetzl, K. Roth K, Comparative immunogenicity assessment of biosimilar natalizumab to its reference medicine: a matching immunogenicity profile, Front. Immunol. 19 (2024) 1414304, doi:https:\/\/doi.org\/10.3389\/fimmu.2024.1414304.","DOI":"10.3389\/fimmu.2024.1414304"},{"key":"10.1016\/j.bbapap.2026.141174_bb0060","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2174\/1389200219666180427165841","article-title":"A review on clinical pharmacokinetics, pharmacodynamics, and pharmacogenomics of natalizumab: a humanized anti-alpha4 integrin monoclonal antibody","volume":"19","author":"Li","year":"2018","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.bbapap.2026.141174_bb0065","doi-asserted-by":"crossref","unstructured":"J.F. Foley, S. Goelz, T. Hoyt, A. Christensen, R.R. Metzger RR, Evaluation of natalizumab pharmacokinetics and pharmacodynamics with standard and extended interval dosing, Mult. Scler. Relat. Disord. 31 (2019) 65\u201371, doi:https:\/\/doi.org\/10.1016\/j.msard.2019.03.017.","DOI":"10.1016\/j.msard.2019.03.017"},{"key":"10.1016\/j.bbapap.2026.141174_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217624","article-title":"Immunoglobulin G structure and rheumatoid factor epitopes","volume":"14","author":"Maibom-Thomsen","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bbapap.2026.141174_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2025.141084","article-title":"Native structure of the monoclonal therapeutic CD20 antibody ocrelizumab","volume":"1873","author":"Chrone","year":"2025","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"key":"10.1016\/j.bbapap.2026.141174_bb0080","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000357982","article-title":"Development, manufacturing and characterization of a highly purified, liquid immunoglobulin G preparation from human plasma","volume":"41","author":"Laursen","year":"2014","journal-title":"Transfus. Med. Hemother."},{"key":"10.1016\/j.bbapap.2026.141174_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218374","article-title":"Enhanced trypsin on a budget: stabilization, purification and high-temperature application of inexpensive commercial trypsin for proteomics applications","volume":"14","author":"Heissel","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bbapap.2026.141174_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2017.01.006","article-title":"Efficient evaluation of humoral immune responses by the use of serum pools","volume":"443","author":"Sternb\u00e6k","year":"2017","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bbapap.2026.141174_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2024.168656","article-title":"xiVIEW: visualisation of crosslinking mass spectrometry data","volume":"436","author":"Combe","year":"2024","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbapap.2026.141174_bb0100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/360369a0","article-title":"The three-dimensional structure of an intact monoclonal antibody for canine lymphoma","volume":"360","author":"Harris","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2026.141174_bb0105","doi-asserted-by":"crossref","unstructured":"L.J. Harris, S.B. Larson, K.W. Hasel, A. McPherson, Refined structure of an intact IgG2a monoclonal antibody, Biochemistry 36 (7) 1581\u201397, doi:https:\/\/doi.org\/10.1021\/bi962514+.","DOI":"10.1021\/bi962514+"},{"key":"10.1016\/j.bbapap.2026.141174_bb0110","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1021\/acsmeasuresciau.1c00032","article-title":"pH dependence of succinimide-ester-based protein cross-linking for structural mass spectrometry applications","volume":"2","author":"Trabjerg","year":"2021","journal-title":"ACS Meas. Sci. Au"},{"key":"10.1016\/j.bbapap.2026.141174_bb0115","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41577-023-00871-z","volume":"23","author":"Rispens","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbapap.2026.141174_bb0120","first-page":"520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"20","author":"Vidarsson","year":"2014","journal-title":"Front. Immunol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963926000518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963926000518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:28:16Z","timestamp":1788985696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570963926000518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1570963926000518"],"URL":"https:\/\/doi.org\/10.1016\/j.bbapap.2026.141174","relation":{},"ISSN":["1570-9639"],"issn-type":[{"value":"1570-9639","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Native structure of the therapeutic IgG4 \u03b14\u03b25 integrin antibody natalizumab","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbapap.2026.141174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"141174"}}